However, differences between BOS patients and non-BOS patients become clear; an increase is seen in the titers of IgG HLA class I antibodies of non-BOS patients compared to BOS patients, while a decrease is shown for titers of IgM HLA class I antibodies of non-BOS patients compared to BOS patients. This evidence concerns the gene CD40LG and Buschke-Ollendorff syndrome.